Evidence map›Paper›PMID 36132960›Full record

ArticleNanoscale advances2021

Addressing challenges in the removal of unbound dye from passively labelled extracellular vesicles.

Kaisa Rautaniemi, Jacopo Zini, Emilia Löfman, Heikki Saari, Iida Haapalehto, Johanna Laukka, Sami Vesamäki, Alexander Efimov, Marjo Yliperttula, Timo Laaksonen and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nanoscale advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Extracellular Vesicle Preparation and Analysis: A State-of-the-Art Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment.International journal of nanomedicine · 2023
    Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kaisa RautaniemiChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.ORCID https://orcid.org/0000-0002-8665-4173
Jacopo ZiniDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki Viikinkaari 5 00790 Helsinki Finland.ORCID https://orcid.org/0000-0001-8021-3679
Emilia LöfmanChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.
Heikki SaariDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki Viikinkaari 5 00790 Helsinki Finland.
Iida HaapalehtoChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.ORCID https://orcid.org/0000-0002-3000-3208
Johanna LaukkaChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.
Sami VesamäkiChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.ORCID https://orcid.org/0000-0001-9994-501X
Alexander EfimovChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.ORCID https://orcid.org/0000-0003-4671-3009
Marjo YliperttulaDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki Viikinkaari 5 00790 Helsinki Finland.
Timo LaaksonenChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.
Elina Vuorimaa-LaukkanenChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.
Ekaterina S LisitsynaChemistry and Advanced Materials, Faculty of Engineering and Natural Sciences, Tampere University Korkeakoulunkatu 8 33720 Tampere Finland ekaterina.lisitsyna@tuni.fi.
Tampere University · FIUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies of extracellular vesicles (EVs), their trafficking and characterization often employ fluorescent labelling. Unfortunately, little attention has been paid thus far to a thorough evaluation of the purification of EVs after labelling, although the presence of an unbound dye may severely compromise the results or even lead to wrong conclusions on EV functionality. Here, we systematically studied five dyes for passive EV labelling and meticulously compared five typical purification methods: ultracentrifugation (UC), ultracentrifugation with discontinuous density gradient (UCG), ultrafiltration (UF), size exclusion chromatography (SEC), and anion exchange chromatography (AEC). A general methodology for evaluation of EV purification efficiency after the labelling was developed and tested to select the purification methods for the chosen dyes. Firstly, we found that some methods initially lead to high EV losses even in the absence of the dye. Secondly, the suitable purification method needs to be found for each particular dye and depends on the physical and chemical properties of the dye. Thirdly, we demonstrated that the developed parameter

Identifiers

PMID36132960
PMCPMC9417910
OpenAlexW3216984929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.